Preclinical agents development against lung fibrosis
This article describes the challenges in the preclinical development of therapeutic agents against lung fibrosis.
Stay updated with breaking news from Oncodesign Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This article describes the challenges in the preclinical development of therapeutic agents against lung fibrosis.
This article dives into the details behind the failure of the preclinical cancer models, reasons,consequences and potential solutions.
Toronto, ON (PRWEB) May 25, 2023 -- Protein kinases act as master regulators of multiple key processes within the cell cycle, and aberrant regulation of their
Toronto, ON (PRWEB) April 26, 2023 -- Currently, chemotherapy is the primary mode of treatment for pancreatic ductal adenocarcinoma (PDAC), a highly
Revenues and operating income in 2022 of €8.3 M (+110% vs. 2021 proforma), including revenues of €8 M, mainly driven by a €7 M milestone and a €0.5 M up-frontNet income almost at break-even (€0.2) MStrong financial visibility with a cash position of €13.4 M ensuring the development of our programs for the coming yea...